All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Amgen Inc. revenue reports

Amgen Inc. financial reports, Amgen Inc. annual revenue in 2020. When does Amgen Inc. report revenue?
Add to widgets
Added to widgets

Amgen Inc. total revenue, net income and dynamics of changes in US dollar today

Amgen Inc. revenue for the past few reporting periods. Net income of Amgen Inc. today amounted to 1 703 000 000 $. Here are the main financial indicators of Amgen Inc.. The financial report chart on our website displays information by dates from 30/06/2017 to 31/12/2019. Amgen Inc. net income is shown in blue on the graph. A graph of the value of all Amgen Inc. assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 6 197 000 000 $ -0.53 % ↓ 1 703 000 000 $ -11.67 % ↓
30/09/2019 5 737 000 000 $ -2.829 % ↓ 1 968 000 000 $ +5.86 % ↑
30/06/2019 5 871 000 000 $ -3.1028 % ↓ 2 179 000 000 $ -5.0958 % ↓
31/03/2019 5 557 000 000 $ +0.054 % ↑ 1 992 000 000 $ -13.804 % ↓
31/12/2018 6 230 000 000 $ - 1 928 000 000 $ -
30/09/2018 5 904 000 000 $ - 1 859 000 000 $ -
30/06/2018 6 059 000 000 $ - 2 296 000 000 $ -
31/03/2018 5 554 000 000 $ - 2 311 000 000 $ -
31/12/2017 5 802 000 000 $ - -4 264 000 000 $ -
30/09/2017 5 773 000 000 $ - 2 021 000 000 $ -
30/06/2017 5 810 000 000 $ - 2 151 000 000 $ -
Show:
to

Amgen Inc. financial report charts

Dates of Amgen Inc. finance reports: 30/06/2017, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Amgen Inc. for today is 31/12/2019. Gross profit Amgen Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Amgen Inc. is 4 944 000 000 $

Amgen Inc. quarterly report dates

Cost of revenue Amgen Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Amgen Inc. is 1 253 000 000 $ Total revenue Amgen Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Amgen Inc. is 6 197 000 000 $ Operating revenue Amgen Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Amgen Inc. is 6 197 000 000 $

Operating income Amgen Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Amgen Inc. is 2 121 000 000 $ Net income Amgen Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Amgen Inc. is 1 703 000 000 $ Current assets Amgen Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Amgen Inc. is 18 440 000 000 $

31/12/2019 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
4 944 000 000 $ 4 701 000 000 $ 4 859 000 000 $ 4 502 000 000 $ 5 134 000 000 $ 4 867 000 000 $ 5 035 000 000 $ 4 610 000 000 $ 4 743 000 000 $ 4 783 000 000 $ 4 786 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 253 000 000 $ 1 036 000 000 $ 1 012 000 000 $ 1 055 000 000 $ 1 096 000 000 $ 1 037 000 000 $ 1 024 000 000 $ 944 000 000 $ 1 059 000 000 $ 990 000 000 $ 1 024 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
6 197 000 000 $ 5 737 000 000 $ 5 871 000 000 $ 5 557 000 000 $ 6 230 000 000 $ 5 904 000 000 $ 6 059 000 000 $ 5 554 000 000 $ 5 802 000 000 $ 5 773 000 000 $ 5 810 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
6 197 000 000 $ 5 737 000 000 $ 5 871 000 000 $ 5 557 000 000 $ 6 230 000 000 $ 5 904 000 000 $ 6 059 000 000 $ 5 343 000 000 $ 5 569 000 000 $ 5 453 000 000 $ 5 574 000 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
2 121 000 000 $ 2 476 000 000 $ 2 678 000 000 $ 2 472 000 000 $ 2 718 000 000 $ 2 647 000 000 $ 2 794 000 000 $ 2 726 000 000 $ 2 245 000 000 $ 2 439 000 000 $ 2 698 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 703 000 000 $ 1 968 000 000 $ 2 179 000 000 $ 1 992 000 000 $ 1 928 000 000 $ 1 859 000 000 $ 2 296 000 000 $ 2 311 000 000 $ -4 264 000 000 $ 2 021 000 000 $ 2 151 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 310 000 000 $ 1 001 000 000 $ 924 000 000 $ 879 000 000 $ 1 182 000 000 $ 926 000 000 $ 869 000 000 $ 760 000 000 $ 1 043 000 000 $ 877 000 000 $ 873 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 076 000 000 $ 3 261 000 000 $ 3 193 000 000 $ 3 085 000 000 $ 3 512 000 000 $ 3 257 000 000 $ 3 265 000 000 $ 1 884 000 000 $ 2 498 000 000 $ 2 344 000 000 $ 2 088 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
18 440 000 000 $ 31 051 000 000 $ 30 746 000 000 $ 35 151 000 000 $ 37 618 000 000 $ 38 320 000 000 $ 37 970 000 000 $ 40 689 000 000 $ 49 476 000 000 $ 49 752 000 000 $ 48 442 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
59 707 000 000 $ 59 535 000 000 $ 59 373 000 000 $ 63 997 000 000 $ 66 416 000 000 $ 67 333 000 000 $ 67 684 000 000 $ 71 164 000 000 $ 79 954 000 000 $ 80 331 000 000 $ 79 587 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
6 037 000 000 $ 11 415 000 000 $ 5 525 000 000 $ 7 358 000 000 $ 6 945 000 000 $ 11 956 000 000 $ 10 131 000 000 $ 9 741 000 000 $ 3 800 000 000 $ 3 000 000 000 $ 2 629 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
12 835 000 000 $ 10 737 000 000 $ 10 622 000 000 $ 12 706 000 000 $ 13 488 000 000 $ 12 432 000 000 $ 11 205 000 000 $ 2 183 000 000 $ 1 152 000 000 $ 1 999 000 000 $ 1 459 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - 32 172 000 000 $ 41 678 000 000 $ 41 351 000 000 $ 39 227 000 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
50 034 000 000 $ 48 608 000 000 $ 48 579 000 000 $ 53 165 000 000 $ 53 916 000 000 $ 52 984 000 000 $ 52 775 000 000 $ 35 541 000 000 $ 35 342 000 000 $ 35 776 000 000 $ 35 062 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
83.80 % 81.65 % 81.82 % 83.07 % 81.18 % 78.69 % 77.97 % 49.94 % 44.20 % 44.54 % 44.05 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
9 673 000 000 $ 10 927 000 000 $ 10 794 000 000 $ 10 832 000 000 $ 12 500 000 000 $ 14 349 000 000 $ 14 909 000 000 $ 15 620 000 000 $ 25 241 000 000 $ 32 229 000 000 $ 31 722 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
2 514 000 000 $ 3 377 000 000 $ 1 414 000 000 $ 1 845 000 000 $ 3 194 000 000 $ 3 273 000 000 $ 2 102 000 000 $ 2 727 000 000 $ 3 012 000 000 $ 3 454 000 000 $ 2 326 000 000 $

Last revenue report of Amgen Inc. was 31/12/2019. According to last financial report total revenue in Amgen Inc. was 6 197 000 000 US dollar and changed by -0.53% since last year. Net income in Amgen Inc. was 1 703 000 000 $ in last quartal, net income changes to -11.67%.

Total assets Amgen Inc. refers to the total amount of assets owned by a person or entity. Total assets Amgen Inc. is 59 707 000 000 $ Current cash Amgen Inc. - the sum of all of the cash a company has on the date of report. Current cash Amgen Inc. is 6 037 000 000 $ Current debt Amgen Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Amgen Inc. is 12 835 000 000 $

Amgen Inc. stocks data

Amgen Inc. financials